Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury

X. Mu, R. D. Azbill, J. E. Springer

Research output: Contribution to journalArticlepeer-review

69 Scopus citations

Abstract

The potential use of riluzole (a glutamate release inhibitor) alone or in combination with methyl-prednisolone (MP) in treating acute spinal cored injury (SCI) was examined. Rats received a contusion injury to the spinal cord using the NYU impactor and were treated with vehicle, riluzole (8 mg/kg), MP(30 mg/kg), or riluzole + MP at 2 and 4 h following injury. Animals continued to receive riluzole treatment (8 mg/kg) for a period of 1 week. The animals were then tested weekly for functional recovery using the BBB open field locomotor score. At the end of testing (6 weeks after injury), each spinal cord was examined for the amount of remaining tissue at the injury site and a myelination index was used to quantify remaining axons in the ventromedial white matter. In this study, only the combination treatment was found to significantly improve behavioral recovery as assessed using the BBB open field locomotor scale. In addition, the combination treatment promoted tissue sparing at the lesion epicenter, but had no clear effect on the index of myelination. The results of this study clearly demonstrate the potential beneficial effects of a combination approach in the treatment of traumatic SCI.

Original languageEnglish
Pages (from-to)773-780
Number of pages8
JournalJournal of Neurotrauma
Volume17
Issue number9
DOIs
StatePublished - 2000

Keywords

  • Excitotoxicity
  • Glucocorticoids
  • Glutamate release
  • Myelin
  • Spinal cord trauma

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury'. Together they form a unique fingerprint.

Cite this